Corcept Therapeutics Incorporated (CORT)
Inventory turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 10,882 | 9,803 | 8,581 | 7,631 | 6,482 | 6,085 | 5,779 | 5,521 | 5,385 | 5,259 | 5,195 | 5,263 | 5,281 | 5,181 | 5,122 | 4,972 | 5,582 | 5,764 | 5,999 | 6,142 |
Inventory | US$ in thousands | 12,412 | 8,050 | 8,350 | 7,190 | 7,730 | 7,513 | 6,915 | 16,565 | 17,031 | 6,046 | 17,415 | 5,079 | 17,950 | 4,994 | 4,669 | 4,948 | 21,157 | 4,817 | 4,927 | 16,147 |
Inventory turnover | 0.88 | 1.22 | 1.03 | 1.06 | 0.84 | 0.81 | 0.84 | 0.33 | 0.32 | 0.87 | 0.30 | 1.04 | 0.29 | 1.04 | 1.10 | 1.00 | 0.26 | 1.20 | 1.22 | 0.38 |
December 31, 2024 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $10,882K ÷ $12,412K
= 0.88
The inventory turnover ratio is a measure of how efficiently a company manages its inventory. It indicates how many times a company's inventory is sold and replaced within a specific period.
Analyzing the inventory turnover of Corcept Therapeutics Incorporated from March 31, 2020, to December 31, 2024, reveals fluctuations in the efficiency of managing inventory. The inventory turnover ratio ranged from a low of 0.26 on December 31, 2020, to a high of 1.22 on June 30, 2020, and September 30, 2024.
A low inventory turnover ratio may suggest overstocking or slow-moving inventory, which could tie up working capital and lead to potential obsolescence or storage costs. On the other hand, a high inventory turnover ratio indicates efficient management of inventory, quick sales turnover, and potentially lower carrying costs.
Corcept Therapeutics experienced some variability in its inventory turnover, with fluctuations observed from quarter to quarter. Overall, the company showed improvements in inventory turnover efficiency, with higher ratios seen in recent quarters, indicating better management of inventory levels.
It is essential for Corcept Therapeutics to monitor its inventory turnover ratio consistently to optimize inventory levels, balance carrying costs, and improve operational efficiency. Additionally, comparing these ratios with industry benchmarks can provide insights into the company's competitive positioning and operational effectiveness.
Peer comparison
Dec 31, 2024
Dec 31, 2024